Literature DB >> 3183357

Abnormal tissue oxygenation in patients with cirrhosis and liver failure.

R Moreau1, S S Lee, T Soupison, J Roche-Sicot, C Sicot.   

Abstract

Systemic haemodynamic and hepatic venous pressures, arterial and mixed venous gases and arterial lactate concentration were measured in 35 patients with histologically proven alcoholic cirrhosis who had been classified into three groups (A, B and C). Eight alcoholic patients without cirrhosis on liver biopsy were also studied. Compared with group A patients, group C patients had significantly higher hepatic venous pressure gradient, cardiac index, O2 transport and arterial lactate concentration and significantly lower systemic vascular resistance, arteriovenous O2 content difference and O2 uptake. In group B patients, corresponding values fell between those of groups A and C. Group A patients, unlike group C patients, were not significantly different from patients without cirrhosis with respect to cardiac index, systemic vascular resistance, O2 uptake and arterial lactate concentration. Our results suggest that in patients with cirrhosis, liver failure-associated hyperdynamic circulation may be accompanied by an abnormal tissue oxygenation.

Entities:  

Mesh:

Year:  1988        PMID: 3183357     DOI: 10.1016/s0168-8278(88)80512-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.

Authors:  Alexander Zipprich; Wajahat Z Mehal; Cristina Ripoll; Roberto J Groszmann
Journal:  Liver Int       Date:  2010-05-24       Impact factor: 5.828

Review 2.  Vasodilatation associated with hepatocellular disease: relation to functional organ failure.

Authors:  S Sherlock
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

3.  Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis.

Authors:  A Gadano; R Moreau; J Heller; C Chagneau; F Vachiéry; C Trombino; A Elman; C Denié; D Valla; D Lebrec
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  A tungsten supplemented diet attenuates bacterial translocation in chronic portal hypertensive and cholestatic rats: role of xanthine dehydrogenase and xanthine oxidase.

Authors:  G Schimpl; M A Pabst; G Feierl; A Kuesz; H Ozbey; S Takahashi; M E Höllwarth
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 5.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

6.  Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?

Authors:  H R Doyle; I R Marino; N Jabbour; G Zetti; J McMichael; S Mitchell; J Fung; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

Review 7.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

Review 8.  Cardiac abnormalities in liver cirrhosis.

Authors:  S S Lee
Journal:  West J Med       Date:  1989-11

Review 9.  Inflammation: a way to understanding the evolution of portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Arturo Cruz; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

Review 10.  Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis.

Authors:  Ramesh Kumar
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.